NIA IMPACT ADVISORS, LLC

Position in GSK — GSK plc

CIK 1815217 OAKLAND, CA

Position in GSK

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$6,344,707

-$368,439 QoQ

Shares Held

121,036

-0.5% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

2.85%

of 13F equity value

Holder Rank

#140

of 1,033 holders

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

NIA IMPACT ADVISORS, LLC holds $13,478,036 across 5 Drug Manufacturers - General names. GSK ranks #1 (47.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc This page	121,036	$6,344,707
2	GILD	Gilead Sciences, Inc.	49,515	$6,255,725
3	PFE	Pfizer Inc	15,005	$361,320
4	ABBV	AbbVie Inc.	1,251	$314,801
5	SNY	Sanofi	4,723	$201,483

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,344,707	121,036	-0.5%	Shares	Sole	2026-08-03
2026-03-31	$6,713,146	121,637	-3.9%	Shares	Sole	2026-05-08
2025-12-31	$6,208,807	126,607	+14.9%	Shares	Sole	2026-02-09
2025-09-30	$4,755,153	110,175	+1.4%	Shares	Sole	2025-11-13
2025-06-30	$4,173,926	108,696	-0.3%	Shares	Sole	2025-08-14
2025-03-31	$4,223,705	109,027	+1421.4%	Shares	Sole	2025-05-15
2022-12-31	$251,813	7,166	-41.3%	Shares	Sole	2023-02-09
2022-09-30	$359,575	12,218	-89.3%	Shares	Sole	2022-11-14
2022-06-30	$4,896,600	114,690	+44.6%	Shares	Sole	2022-08-05
2022-03-31	$3,387,771	79,295	—	Shares	Sole	2022-05-11
No filing history on record for this holder in this stock.